天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

武漢敬康恩生物醫(yī)藥科技有限公司 公司信息

公司名稱: 武漢敬康恩生物醫(yī)藥科技有限公司
電話: 13720134139 +86 -0-15871494362
電子郵件:orders@jknbiochem.com
國籍:中國
網(wǎng)址: www.jknbiochem.com
產(chǎn)品總數(shù):5821
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

公司提供產(chǎn)品列表

Rafivirumab 瑞非韋魯 944548-37-2
Arcitumomab 阿西莫單抗 154361-48-5
Satumomab 沙妥莫單抗 144058-40-2
Gevokizumab 吉伏組單抗 1129435-60-4
Ranibizumab 雷尼株單抗 347396-82-1
Pascolizumab Sb-240683 331243-22-2
Oregovomab OregovoMab 213327-37-8
Research Grade Tecnemab
Iodine (131I) Derlotuximab Biotin Cotara (9CI) 340013-96-9
Basiliximab 巴利昔單抗 179045-86-4
Tositumomab bexxar 208921-02-2
Research Grade Immurait-Ll2Mab
Sevirumab 司韋單抗
Visilizumab VISILIZUMAB 219716-33-3
Mitumomab Mitumomab 216503-58-1
Research Grade Cc49
Gavilimomab Immunoglobulin M,anti-(human CD147 (antigen)) (mouse monoclonal ABX-CBL m-chain), disulfide with mousemonoclonal ABX-CBL light chain, pentamer 244096-20-6
Foravirumab 夫瑞韋如 944548-38-3
Milatuzumab 米拉組單抗 899796-83-9
Tadocizumab tadocizumab 339086-80-5
Dacliximab 達(dá)昔單抗 152923-56-3
Apalutamide 阿帕魯胺 956104-40-8
Abemaciclib 阿貝西利 1231929-97-7
Bevacizumab 貝伐珠單抗 216974-75-3
Natalizumab 那他珠單抗 189261-10-7
Omalizumab 奧馬珠單抗 242138-07-4
Amatuximab 阿麥妥單抗 931402-35-6
palivizumab 帕利珠單抗 188039-54-5
Matuzumab 馬妥珠單抗 339186-68-4
Narsoplimab NARSOPLIMAB (納索利單抗 ) 2108782-45-0
Lorvotuzumab Mertansine Lorvotuzumab Mertansine 1008106-64-6
Sarilumab SARILUMAB 1189541-98-7
Research Grade Fontolizumab Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer 326859-36-3
dupilumab 度匹魯單抗 1190264-60-8
nimotuzumab nimotuzumab 828933-51-3
Labetuzumab Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer 219649-07-7
Pertuzumab 帕妥珠單抗 380610-27-5
Motavizumab 莫維珠單抗 677010-34-3
Naptumomab Estafenatox 埃托-那普妥莫單抗 676258-98-3
Research Grade Cedelizumab Immunoglobulin G4,anti-(human CD4 (antigen)) (human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted g4-chain), disulfide with human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted k-chain, dimer (9CI) 156586-90-2
Ixekizumab 伊西貝單抗 1143503-69-8
Nivolumab 納武單抗 946414-94-4
Ruplizumab RUPLIZUMAB 220651-94-5
Gemtuzumab 吉妥珠單抗奧唑米星 220578-59-6
EFALIZUMABUM EFALIZUMABUM 214745-43-4
Lambrolizumab 派姆單抗 1374853-91-4
TocilizuMab 托珠單抗 375823-41-9
Lymphocide Lymphocide 205923-57-5
Eculizumab 托西珠單抗 219685-50-4
Hu1D10 Hu1D10 267227-08-7
cantuzumab mertansine cantuzumab mertansine 400010-39-1
Topiroxostat 托匹司他 577778-58-6
Vonoprazan 沃諾拉贊 881681-00-1
Neratinib 來那替尼 688387-09-6
ApreMilast 阿普斯特 608141-41-9
Carbazochrome Sodium Sulfonate 卡絡(luò)磺鈉 51460-26-5
1-Methylcyclopropanecarboxylic acid 1-甲基環(huán)丙烷-1-羧酸 6914-76-7
Pomalidomide 泊馬度胺 19171-19-8
(R)-(-)-2,2-dimethyl-1,3-dioxolane-4-methanol (R)-(-)-甘油醇縮丙酮 14347-78-5
4,4-dimethyl-3,5,8- trioxabicyclo[5.1.0]octane 4,4-二甲基-3,5,8-三氧雜雙環(huán)[5,1,0]辛烷 57280-22-5
Erlotinib Hydrochloride 埃羅替尼 183321-74-6
Ibrutinib (PCI-32765) 依魯替尼 936563-96-1
Olaparib 奧拉帕尼 763113-22-0
Crisaborole 克立硼羅 906673-24-3
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate 2-(3-醛基-4-異丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯 161798-03-4
Febuxostat 非布司他 144060-53-7
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate 2-(4-羥基苯基)-4-甲基噻唑-5-羧酸乙酯 161797-99-5
4-hydroxythiobenzamide 4-羥基硫代苯甲酰胺 25984-63-8
Ethyl 2-(3-formyl-4- hydroxyphenyl)-4- methylthiazole-5-carboxylate 2-(3-醛基-4-羥基苯基)-4-甲基噻唑-5-羧酸乙酯 161798-01-2
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate 2-(3-氰基-4-羥基苯基)-4-甲基-1,3-噻唑-5-羧酸乙酯 161798-02-3
Entecavir hydrate 恩替卡韋一水合物 209216-23-9
(4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one (4S)-3-[(5S)-5-(4-氟苯基)-5-羥基戊酰基]-4-苯基-1,3-氧氮雜環(huán)戊烷-2-酮 189028-95-3
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate 2-(3-氰基-4-異丁氧基苯基)-4-甲基-5-噻唑甲酸乙酯 160844-75-7
(S)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione (4S)-3-[5-(4-氟苯基)-1,5-二氧代戊基]-4-苯基-2-惡唑烷酮 189028-93-1
Ezetimibe 依折麥布 163222-33-1
Diisopropylamine dichloroacetate 二氯醋酸二異丙胺 660-27-5
NEW PRODUCTS INTRODUCTION
Lintuzumab Lintuzumab 166089-32-3
Alemtuzumab 阿倫單抗 216503-57-0
Siplizumab SIPLIZUMAB ( 西利珠單抗 ) 288392-69-8
Pexelizumab h5G1.1-scFv 219685-93-5
Siltuximab SILTUXIMAB ( 塞妥昔單抗 ) 541502-14-1
mepolizumab 美泊利單抗 196078-29-2
Edrecolomab 依決洛單抗 156586-89-9
Research Grade Afelimomab 阿非莫單抗 156227-98-4
Igovomab 伊戈伏單抗 171656-50-1
Capromab CAPROMAB 145464-28-4
Sulesomab 硫索單抗 167747-19-5
Research Grade cT84.66
Abciximab ABCIXIMAB 143653-53-6
Research Grade T10B9.1A-31
Enlimomab 恩莫單抗 142864-19-5
Abagovomab ABAGOVOMAB 792921-10-9
Inolimomab 伊諾莫單抗 152981-31-2
Odulimomab 奧度莫單抗 159445-64-4
Edobacomab 埃巴單抗 141410-98-2
Biciromab Biciromab 138783-13-8
Imciromab 英西單抗 126132-83-0
Nofetumomab Merpentan 165942-79-0
Bavituximab 巴維昔單抗 648904-28-3
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2007? ChemicalBook. All rights reserved.